Caveolin-1 promotes tumor growth and metastasis via autophagy inhibition in hepatocellular carcinoma
Caveolin-1 is a member of the caveolae family of membrane proteins. Although some researchers have investigated the function of Caveolin-1 in hepatocellular carcinoma, the mechanism of Caveolin-1 action and its prognostic value in hepatocellular carcinoma remain unclear. Caveolin-1 expression was me...
Saved in:
Published in | Clinics and research in hepatology and gastroenterology Vol. 40; no. 2; pp. 169 - 178 |
---|---|
Main Authors | , , , , , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
France
Elsevier Masson SAS
01.04.2016
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | Caveolin-1 is a member of the caveolae family of membrane proteins. Although some researchers have investigated the function of Caveolin-1 in hepatocellular carcinoma, the mechanism of Caveolin-1 action and its prognostic value in hepatocellular carcinoma remain unclear.
Caveolin-1 expression was measured in hepatocellular carcinoma cell lines and tissues using quantitative reverse transcription-polymerase chain reaction, western blot, and immunofluorescence assays. In in vitro experiments, Caveolin-1 was depleted using a short hairpin RNA lentiviral vector, and tumor cell behavior was analyzed. The effect of Caveolin-1 on hepatocellular carcinoma cell autophagy was investigated. Prognostic value of Caveolin-1 was analyzed by immunohistochemistry in two cohorts that included a total of 721 hepatocellular carcinoma patients.
We found that Caveolin-1 was overexpressed in highly metastatic hepatocellular carcinoma cell lines and tumor tissues. Moreover, Caveolin-1 promoted hepatocellular carcinoma cell proliferation, migration, and angiogenesis and inhibited autophagy. Finally, Caveolin-1 expression in hepatocellular carcinoma tissues was inversely correlated with patient overall survival and time to recurrence.
Our data obtained from cell lines suggest an oncogenic role for Caveolin-1 in hepatocellular carcinoma, Caveolin-1 contributed to hepatocellular carcinoma cell autophagy deficiency. Furthermore, Caveolin-1 may function as a novel prognostic indicator for hepatocellular carcinoma patients after curative resection, and combination of targeted therapy aimed at Caveolin-1 and autophagy modulation may represent an effective way to treat hepatocellular carcinoma. |
---|---|
AbstractList | Summary Background Caveolin-1 is a member of the caveolae family of membrane proteins. Although some researchers have investigated the function of Caveolin-1 in hepatocellular carcinoma, the mechanism of Caveolin-1 action and its prognostic value in hepatocellular carcinoma remain unclear. Methods Caveolin-1 expression was measured in hepatocellular carcinoma cell lines and tissues using quantitative reverse transcription-polymerase chain reaction, western blot, and immunofluorescence assays. In in vitro experiments, Caveolin-1 was depleted using a short hairpin RNA lentiviral vector, and tumor cell behavior was analyzed. The effect of Caveolin-1 on hepatocellular carcinoma cell autophagy was investigated. Prognostic value of Caveolin-1 was analyzed by immunohistochemistry in two cohorts that included a total of 721 hepatocellular carcinoma patients. Results We found that Caveolin-1 was overexpressed in highly metastatic hepatocellular carcinoma cell lines and tumor tissues. Moreover, Caveolin-1 promoted hepatocellular carcinoma cell proliferation, migration, and angiogenesis and inhibited autophagy. Finally, Caveolin-1 expression in hepatocellular carcinoma tissues was inversely correlated with patient overall survival and time to recurrence. Conclusion Our data obtained from cell lines suggest an oncogenic role for Caveolin-1 in hepatocellular carcinoma, Caveolin-1 contributed to hepatocellular carcinoma cell autophagy deficiency. Furthermore, Caveolin-1 may function as a novel prognostic indicator for hepatocellular carcinoma patients after curative resection, and combination of targeted therapy aimed at Caveolin-1 and autophagy modulation may represent an effective way to treat hepatocellular carcinoma. Caveolin-1 is a member of the caveolae family of membrane proteins. Although some researchers have investigated the function of Caveolin-1 in hepatocellular carcinoma, the mechanism of Caveolin-1 action and its prognostic value in hepatocellular carcinoma remain unclear. Caveolin-1 expression was measured in hepatocellular carcinoma cell lines and tissues using quantitative reverse transcription-polymerase chain reaction, western blot, and immunofluorescence assays. In in vitro experiments, Caveolin-1 was depleted using a short hairpin RNA lentiviral vector, and tumor cell behavior was analyzed. The effect of Caveolin-1 on hepatocellular carcinoma cell autophagy was investigated. Prognostic value of Caveolin-1 was analyzed by immunohistochemistry in two cohorts that included a total of 721 hepatocellular carcinoma patients. We found that Caveolin-1 was overexpressed in highly metastatic hepatocellular carcinoma cell lines and tumor tissues. Moreover, Caveolin-1 promoted hepatocellular carcinoma cell proliferation, migration, and angiogenesis and inhibited autophagy. Finally, Caveolin-1 expression in hepatocellular carcinoma tissues was inversely correlated with patient overall survival and time to recurrence. Our data obtained from cell lines suggest an oncogenic role for Caveolin-1 in hepatocellular carcinoma, Caveolin-1 contributed to hepatocellular carcinoma cell autophagy deficiency. Furthermore, Caveolin-1 may function as a novel prognostic indicator for hepatocellular carcinoma patients after curative resection, and combination of targeted therapy aimed at Caveolin-1 and autophagy modulation may represent an effective way to treat hepatocellular carcinoma. Caveolin-1 is a member of the caveolae family of membrane proteins. Although some researchers have investigated the function of Caveolin-1 in hepatocellular carcinoma, the mechanism of Caveolin-1 action and its prognostic value in hepatocellular carcinoma remain unclear.BACKGROUNDCaveolin-1 is a member of the caveolae family of membrane proteins. Although some researchers have investigated the function of Caveolin-1 in hepatocellular carcinoma, the mechanism of Caveolin-1 action and its prognostic value in hepatocellular carcinoma remain unclear.Caveolin-1 expression was measured in hepatocellular carcinoma cell lines and tissues using quantitative reverse transcription-polymerase chain reaction, western blot, and immunofluorescence assays. In in vitro experiments, Caveolin-1 was depleted using a short hairpin RNA lentiviral vector, and tumor cell behavior was analyzed. The effect of Caveolin-1 on hepatocellular carcinoma cell autophagy was investigated. Prognostic value of Caveolin-1 was analyzed by immunohistochemistry in two cohorts that included a total of 721 hepatocellular carcinoma patients.METHODSCaveolin-1 expression was measured in hepatocellular carcinoma cell lines and tissues using quantitative reverse transcription-polymerase chain reaction, western blot, and immunofluorescence assays. In in vitro experiments, Caveolin-1 was depleted using a short hairpin RNA lentiviral vector, and tumor cell behavior was analyzed. The effect of Caveolin-1 on hepatocellular carcinoma cell autophagy was investigated. Prognostic value of Caveolin-1 was analyzed by immunohistochemistry in two cohorts that included a total of 721 hepatocellular carcinoma patients.We found that Caveolin-1 was overexpressed in highly metastatic hepatocellular carcinoma cell lines and tumor tissues. Moreover, Caveolin-1 promoted hepatocellular carcinoma cell proliferation, migration, and angiogenesis and inhibited autophagy. Finally, Caveolin-1 expression in hepatocellular carcinoma tissues was inversely correlated with patient overall survival and time to recurrence.RESULTSWe found that Caveolin-1 was overexpressed in highly metastatic hepatocellular carcinoma cell lines and tumor tissues. Moreover, Caveolin-1 promoted hepatocellular carcinoma cell proliferation, migration, and angiogenesis and inhibited autophagy. Finally, Caveolin-1 expression in hepatocellular carcinoma tissues was inversely correlated with patient overall survival and time to recurrence.Our data obtained from cell lines suggest an oncogenic role for Caveolin-1 in hepatocellular carcinoma, Caveolin-1 contributed to hepatocellular carcinoma cell autophagy deficiency. Furthermore, Caveolin-1 may function as a novel prognostic indicator for hepatocellular carcinoma patients after curative resection, and combination of targeted therapy aimed at Caveolin-1 and autophagy modulation may represent an effective way to treat hepatocellular carcinoma.CONCLUSIONOur data obtained from cell lines suggest an oncogenic role for Caveolin-1 in hepatocellular carcinoma, Caveolin-1 contributed to hepatocellular carcinoma cell autophagy deficiency. Furthermore, Caveolin-1 may function as a novel prognostic indicator for hepatocellular carcinoma patients after curative resection, and combination of targeted therapy aimed at Caveolin-1 and autophagy modulation may represent an effective way to treat hepatocellular carcinoma. |
Author | Zhou, Jian Jiang, Xi-Fei Fan, Jia Liu, Wei-Ren Gao, Dong-Mei Dai, Zhi Yang, Liu-Xiao Qiu, Shuang-Jian Shi, Ying-Hong Peng, Yuan-Fei Jin, Lei Tian, Meng-Xin Shen, Ying-Hao Ding, Zhen-Bin |
Author_xml | – sequence: 1 givenname: Wei-Ren surname: Liu fullname: Liu, Wei-Ren organization: Department of Liver Surgery, Liver Cancer Institute, Zhongshan Hospital, Fudan University, 180, FengLin Road, 200032 Shanghai, China – sequence: 2 givenname: Lei surname: Jin fullname: Jin, Lei organization: Department of Liver Surgery, Liver Cancer Institute, Zhongshan Hospital, Fudan University, 180, FengLin Road, 200032 Shanghai, China – sequence: 3 givenname: Meng-Xin surname: Tian fullname: Tian, Meng-Xin organization: Department of Liver Surgery, Liver Cancer Institute, Zhongshan Hospital, Fudan University, 180, FengLin Road, 200032 Shanghai, China – sequence: 4 givenname: Xi-Fei surname: Jiang fullname: Jiang, Xi-Fei organization: Department of Liver Surgery, Liver Cancer Institute, Zhongshan Hospital, Fudan University, 180, FengLin Road, 200032 Shanghai, China – sequence: 5 givenname: Liu-Xiao surname: Yang fullname: Yang, Liu-Xiao organization: Department of Liver Surgery, Liver Cancer Institute, Zhongshan Hospital, Fudan University, 180, FengLin Road, 200032 Shanghai, China – sequence: 6 givenname: Zhen-Bin surname: Ding fullname: Ding, Zhen-Bin organization: Department of Liver Surgery, Liver Cancer Institute, Zhongshan Hospital, Fudan University, 180, FengLin Road, 200032 Shanghai, China – sequence: 7 givenname: Ying-Hao surname: Shen fullname: Shen, Ying-Hao organization: Department of Liver Surgery, Liver Cancer Institute, Zhongshan Hospital, Fudan University, 180, FengLin Road, 200032 Shanghai, China – sequence: 8 givenname: Yuan-Fei surname: Peng fullname: Peng, Yuan-Fei organization: Department of Liver Surgery, Liver Cancer Institute, Zhongshan Hospital, Fudan University, 180, FengLin Road, 200032 Shanghai, China – sequence: 9 givenname: Dong-Mei surname: Gao fullname: Gao, Dong-Mei organization: Department of Liver Surgery, Liver Cancer Institute, Zhongshan Hospital, Fudan University, 180, FengLin Road, 200032 Shanghai, China – sequence: 10 givenname: Jian surname: Zhou fullname: Zhou, Jian organization: Department of Liver Surgery, Liver Cancer Institute, Zhongshan Hospital, Fudan University, 180, FengLin Road, 200032 Shanghai, China – sequence: 11 givenname: Shuang-Jian surname: Qiu fullname: Qiu, Shuang-Jian organization: Department of Liver Surgery, Liver Cancer Institute, Zhongshan Hospital, Fudan University, 180, FengLin Road, 200032 Shanghai, China – sequence: 12 givenname: Zhi surname: Dai fullname: Dai, Zhi organization: Department of Liver Surgery, Liver Cancer Institute, Zhongshan Hospital, Fudan University, 180, FengLin Road, 200032 Shanghai, China – sequence: 13 givenname: Jia surname: Fan fullname: Fan, Jia organization: Department of Liver Surgery, Liver Cancer Institute, Zhongshan Hospital, Fudan University, 180, FengLin Road, 200032 Shanghai, China – sequence: 14 givenname: Ying-Hong surname: Shi fullname: Shi, Ying-Hong email: shi.yinghong@zs-hospital.sh.cn organization: Department of Liver Surgery, Liver Cancer Institute, Zhongshan Hospital, Fudan University, 180, FengLin Road, 200032 Shanghai, China |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/26206578$$D View this record in MEDLINE/PubMed |
BookMark | eNqFkV9rFDEUxYNUbK39BiJ59GXGm8xkMisiyOI_KPjQCr6FTHKnm3VmsiaZlf32Zrq1D4VqCOQ-nPNLcs5zcjL5CQl5yaBkwJo329IMbgpYcmCihKYEJp-QM84ZFLJmP07uZ2Cn5CLGLeRVC2gle0ZOecOhEbI9I3at9-gzq2B0F_zoE0aa5tEHehP877SherJ0xKRj3i7SvdNUz8nvNvrmQN20cZ1Lzk95pBvc6eQNDsM86ECNDsZNftQvyNNeDxEv7s5z8v3Tx-v1l-Ly2-ev6w-XhalbloqOc9EYbG0vVi1gbbq-NrYB5J1E0fdoq1WLwpqOdRzQVKKyohF1y-3Kauyqc_L6yM0_-TVjTGp0cXmOntDPUTEpWwmSM5mlr-6kczeiVbvgRh0O6m8yWVAfBSb4GAP29xIGaulAbdWxA7V0oKBRcMt9-8BmXNJLQCloN_zP_P5oxhzS3mG4FTmjh594wLj1c5hyfoqpyBWoq6XipWEmIFOqVQa8exygrHf_vv8PzPK64A |
CitedBy_id | crossref_primary_10_1016_j_atherosclerosis_2025_119113 crossref_primary_10_1097_MD_0000000000007359 crossref_primary_10_3390_ijms21114171 crossref_primary_10_1002_ijc_31369 crossref_primary_10_2147_CMAR_S264673 crossref_primary_10_1186_s12943_016_0558_7 crossref_primary_10_1111_eci_14065 crossref_primary_10_1186_s12964_023_01053_z crossref_primary_10_1016_j_omto_2021_10_005 crossref_primary_10_1016_j_yexcr_2017_07_004 crossref_primary_10_3389_fphar_2023_1237456 crossref_primary_10_1038_s41419_018_0795_3 crossref_primary_10_1063_1_5024386 crossref_primary_10_1007_s00232_020_00160_z crossref_primary_10_1007_s10555_020_09890_x crossref_primary_10_3390_cells9020367 crossref_primary_10_1093_carcin_bgab080 crossref_primary_10_1111_cas_13659 crossref_primary_10_1007_s11010_017_3003_3 crossref_primary_10_1007_s10719_021_09998_4 crossref_primary_10_2147_IJN_S282172 crossref_primary_10_3390_biom9080314 crossref_primary_10_3390_molecules24203651 crossref_primary_10_3892_etm_2017_5038 crossref_primary_10_1016_j_cca_2020_11_020 crossref_primary_10_3389_fphys_2019_01606 crossref_primary_10_1080_14756366_2023_2288806 |
Cites_doi | 10.3322/caac.20107 10.1158/0008-5472.CAN-11-3102 10.1038/nm843 10.4161/cc.10.24.18551 10.1002/hep.22393 10.4161/cc.9.21.13817 10.1016/j.biocel.2011.01.023 10.1007/s00432-004-0564-9 10.1158/0008-5472.CAN-12-0777 10.1158/0008-5472.CAN-10-4249 10.4161/auto.7.10.16818 10.1016/j.bbrc.2006.03.246 10.1158/1078-0432.CCR-12-0183 10.1146/annurev-pathol-011811-120856 10.3389/fphys.2011.00120 10.1016/j.cell.2011.05.040 10.1038/onc.2011.154 10.1158/0008-5472.CAN-12-0448 10.1016/S0140-6736(11)61347-0 10.1016/j.febslet.2013.02.002 10.1007/s12032-011-9900-5 10.1016/j.ejca.2013.08.016 10.1158/0008-5472.CAN-12-3040 10.1016/S1937-6448(08)01804-2 10.3109/00313025.2010.494293 10.1002/path.3957 10.1200/JCO.2006.09.4565 10.1186/1471-2407-9-65 10.1056/NEJMcibr1114526 |
ContentType | Journal Article |
Copyright | 2015 Elsevier Masson SAS Elsevier Masson SAS Copyright © 2015 Elsevier Masson SAS. All rights reserved. |
Copyright_xml | – notice: 2015 Elsevier Masson SAS – notice: Elsevier Masson SAS – notice: Copyright © 2015 Elsevier Masson SAS. All rights reserved. |
DBID | AAYXX CITATION CGR CUY CVF ECM EIF NPM 7X8 |
DOI | 10.1016/j.clinre.2015.06.017 |
DatabaseName | CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed MEDLINE - Academic |
DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) MEDLINE - Academic |
DatabaseTitleList | MEDLINE MEDLINE - Academic |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine |
EISSN | 2210-741X |
EndPage | 178 |
ExternalDocumentID | 26206578 10_1016_j_clinre_2015_06_017 1_s2_0_S2210740115001539 S2210740115001539 |
Genre | Research Support, Non-U.S. Gov't Journal Article |
GroupedDBID | --M .1- .55 .FO .~1 08J 08T 0R~ 1P~ 1~. 4.4 457 4G. 53G 5VS 7-5 8P~ AAEDT AAEDW AAIKJ AAKOC AALRI AAOAW AATTM AAXKI AAXUO AAYWO ABJNI ABMAC ABMZM ABWVN ABXDB ACDAQ ACGFS ACIEU ACRLP ACRPL ACVFH ADBBV ADCNI ADEZE ADMUD ADNMO ADVLN AEBSH AEIPS AEKER AENEX AEUPX AEVXI AFJKZ AFPUW AFRHN AFTJW AFXIZ AGCQF AGHFR AGUBO AGYEJ AIEXJ AIGII AIIUN AIKHN AITUG AJRQY AJUYK AKBMS AKRWK AKYEP ALMA_UNASSIGNED_HOLDINGS AMRAJ ANKPU ANZVX APXCP AXJTR BKOJK BLXMC BNPGV EBS EFJIC EFKBS EJD F5P FDB FIRID FNPLU FYGXN GBLVA HZ~ J1W KOM MO0 O-L O9- OAUVE OC. ON0 P-8 P-9 PC. Q38 ROL SDF SEM SES SPCBC SSH SSZ T5K X7M Z5R ~G- AACTN AFKWA AJOXV AMFUW RIG AAYXX AGRNS CITATION CGR CUY CVF ECM EIF NPM 7X8 |
ID | FETCH-LOGICAL-c481t-b2256ce8df5980e4cbf4cd60e2b7e5ffed398e5dcb1b20ec353d565482d9daeb3 |
ISSN | 2210-7401 2210-741X |
IngestDate | Fri Jul 11 08:53:44 EDT 2025 Mon Jul 21 05:59:33 EDT 2025 Thu Apr 24 22:59:23 EDT 2025 Tue Jul 01 00:58:37 EDT 2025 Tue Feb 25 19:56:02 EST 2025 Tue Aug 26 16:39:12 EDT 2025 |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 2 |
Keywords | Cav-1 TNM TTR OS CI qRT-PCR γ-GT HCC TMA HR AFP EMT Caveolin-1 Quantitative reverse transcription-polymerase chain reaction Confidential interval Hepatocellular carcinoma Time to recurrence Tissue microarray Hazard ratio Epithelial-to-mesenchymal transition γ-glutamyl transferase α-fetoprotein Overall survival Tumor-nodes-metastasis |
Language | English |
License | Copyright © 2015 Elsevier Masson SAS. All rights reserved. |
LinkModel | OpenURL |
MergedId | FETCHMERGED-LOGICAL-c481t-b2256ce8df5980e4cbf4cd60e2b7e5ffed398e5dcb1b20ec353d565482d9daeb3 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
PMID | 26206578 |
PQID | 1778707217 |
PQPubID | 23479 |
PageCount | 10 |
ParticipantIDs | proquest_miscellaneous_1778707217 pubmed_primary_26206578 crossref_primary_10_1016_j_clinre_2015_06_017 crossref_citationtrail_10_1016_j_clinre_2015_06_017 elsevier_clinicalkeyesjournals_1_s2_0_S2210740115001539 elsevier_clinicalkey_doi_10_1016_j_clinre_2015_06_017 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | 2016-04-01 |
PublicationDateYYYYMMDD | 2016-04-01 |
PublicationDate_xml | – month: 04 year: 2016 text: 2016-04-01 day: 01 |
PublicationDecade | 2010 |
PublicationPlace | France |
PublicationPlace_xml | – name: France |
PublicationTitle | Clinics and research in hepatology and gastroenterology |
PublicationTitleAlternate | Clin Res Hepatol Gastroenterol |
PublicationYear | 2016 |
Publisher | Elsevier Masson SAS |
Publisher_xml | – name: Elsevier Masson SAS |
References | Gao, Qiu, Fan, Zhou, Wang, Xiao (bib0240) 2007; 25 Huang, Ding, Gu, Zhou, Kuang, Ji (bib0250) 2012; 18 Yu, Fan, Liu, Zhang, Wang, Zhang (bib0195) 2013; 587 Wu, Queenan, Brody, Potoczek, Sotgia, Lisanti (bib0185) 2011; 10 Chiu, Lee, Huang, Aldape, Yao, Steeg (bib0190) 2011; 71 Yang, Yang, Huang, Wang, Lu, Tsai (bib0215) 2010; 42 Jemal, Bray, Center, Ferlay, Ward, Forman (bib0150) 2011; 61 Du, Qian, Papageorge, Schetter, Vass, Liu (bib0205) 2012; 72 Zhou, Jia, Wang, Wang, Chu, Hu (bib0255) 2006; 345 Tahir, Yang, Goltsov, Song, Ren, Wang (bib0175) 2013; 73 Martinez-Outschoorn, Whitaker-Menezes, Pavlides, Chiavarina, Bonuccelli, Casey (bib0285) 2010; 9 Forner, Llovet, Bruix (bib0155) 2012; 379 Tse, Ko, Tung, Chan, Lee, Ngan (bib0200) 2012; 226 Kannan, Krishnan, Ali, Subramaniam, Halagowder, Sivasithamparam (bib0170) 2014; 50 Ha, Her, Lee, Ryu, Lee, Han (bib0270) 2012; 72 Li, Tian, Yang, Zhao, Wu, Ye (bib0220) 2004; 130 Martinez-Outschoorn, Pavlides, Howell, Pestell, Tanowitz, Sotgia (bib0280) 2011; 43 Cokakli, Erdal, Nart, Yilmaz, Sagol, Kilic (bib0260) 2009; 9 Shi, Ding, Zhou, He, Xu, Gambotto (bib0245) 2008; 48 Sotgia, Martinez-Outschoorn, Howell, Pestell, Pavlides, Lisanti (bib0275) 2012; 7 Tang, Zeng, He, Liao, Qian, Toi (bib0210) 2012; 29 Ye, Qin, Forgues, He, Kim, Peng (bib0225) 2003; 9 Parat (bib0165) 2009; 273 Goetz, Minguet, Navarro-Lerida, Lazcano, Samaniego, Calvo (bib0290) 2011; 146 Sowa (bib0160) 2012; 2 Weiner, Lotze (bib0265) 2012; 366 Shi, Ding, Zhou, Hui, Shi, Ke (bib0230) 2011; 7 Huang, Qiu, Wang, Peng, Jia, Logsdon (bib0180) 2012; 72 Jiang, Liu, Guo, Zhang, Zhi, Ji (bib0235) 2011; 30 Tahir (10.1016/j.clinre.2015.06.017_bib0175) 2013; 73 Jemal (10.1016/j.clinre.2015.06.017_bib0150) 2011; 61 Ye (10.1016/j.clinre.2015.06.017_bib0225) 2003; 9 Zhou (10.1016/j.clinre.2015.06.017_bib0255) 2006; 345 Li (10.1016/j.clinre.2015.06.017_bib0220) 2004; 130 Cokakli (10.1016/j.clinre.2015.06.017_bib0260) 2009; 9 Sotgia (10.1016/j.clinre.2015.06.017_bib0275) 2012; 7 Shi (10.1016/j.clinre.2015.06.017_bib0230) 2011; 7 Parat (10.1016/j.clinre.2015.06.017_bib0165) 2009; 273 Gao (10.1016/j.clinre.2015.06.017_bib0240) 2007; 25 Forner (10.1016/j.clinre.2015.06.017_bib0155) 2012; 379 Sowa (10.1016/j.clinre.2015.06.017_bib0160) 2012; 2 Ha (10.1016/j.clinre.2015.06.017_bib0270) 2012; 72 Huang (10.1016/j.clinre.2015.06.017_bib0250) 2012; 18 Chiu (10.1016/j.clinre.2015.06.017_bib0190) 2011; 71 Du (10.1016/j.clinre.2015.06.017_bib0205) 2012; 72 Tse (10.1016/j.clinre.2015.06.017_bib0200) 2012; 226 Yu (10.1016/j.clinre.2015.06.017_bib0195) 2013; 587 Yang (10.1016/j.clinre.2015.06.017_bib0215) 2010; 42 Shi (10.1016/j.clinre.2015.06.017_bib0245) 2008; 48 Goetz (10.1016/j.clinre.2015.06.017_bib0290) 2011; 146 Tang (10.1016/j.clinre.2015.06.017_bib0210) 2012; 29 Martinez-Outschoorn (10.1016/j.clinre.2015.06.017_bib0285) 2010; 9 Huang (10.1016/j.clinre.2015.06.017_bib0180) 2012; 72 Jiang (10.1016/j.clinre.2015.06.017_bib0235) 2011; 30 Weiner (10.1016/j.clinre.2015.06.017_bib0265) 2012; 366 Kannan (10.1016/j.clinre.2015.06.017_bib0170) 2014; 50 Wu (10.1016/j.clinre.2015.06.017_bib0185) 2011; 10 Martinez-Outschoorn (10.1016/j.clinre.2015.06.017_bib0280) 2011; 43 |
References_xml | – volume: 48 start-page: 497 year: 2008 end-page: 507 ident: bib0245 article-title: Expression of X-linked inhibitor-of-apoptosis protein in hepatocellular carcinoma promotes metastasis and tumor recurrence publication-title: Hepatology – volume: 43 start-page: 1045 year: 2011 end-page: 1051 ident: bib0280 article-title: Stromal-epithelial metabolic coupling in cancer: integrating autophagy and metabolism in the tumor microenvironment publication-title: Int J Biochem Cell Biol – volume: 18 start-page: 3042 year: 2012 end-page: 3053 ident: bib0250 article-title: Decreased selenium-binding protein 1 enhances glutathione peroxidase 1 activity and downregulates HIF-1alpha to promote hepatocellular carcinoma invasiveness publication-title: Clin Cancer Res – volume: 9 start-page: 65 year: 2009 ident: bib0260 article-title: Differential expression of Caveolin-1 in hepatocellular carcinoma: correlation with differentiation state, motility and invasion publication-title: BMC Cancer – volume: 7 start-page: 423 year: 2012 end-page: 467 ident: bib0275 article-title: Caveolin-1 and cancer metabolism in the tumor microenvironment: markers, models, and mechanisms publication-title: Annu Rev Pathol – volume: 61 start-page: 69 year: 2011 end-page: 90 ident: bib0150 article-title: Global cancer statistics publication-title: CA Cancer J Clin – volume: 587 start-page: 782 year: 2013 end-page: 787 ident: bib0195 article-title: Caveolin-1 up-regulates integrin alpha2,6-sialylation to promote integrin alpha5beta1-dependent hepatocarcinoma cell adhesion publication-title: FEBS Lett – volume: 50 start-page: 204 year: 2014 end-page: 215 ident: bib0170 article-title: Caveolin-1 promotes gastric cancer progression by up-regulating epithelial to mesenchymal transition by crosstalk of signalling mechanisms under hypoxic condition publication-title: Eur J Cancer – volume: 73 start-page: 1900 year: 2013 end-page: 1911 ident: bib0175 article-title: Caveolin-1-LRP6 signaling module stimulates aerobic glycolysis in prostate cancer publication-title: Cancer Res – volume: 146 start-page: 148 year: 2011 end-page: 163 ident: bib0290 article-title: Biomechanical remodeling of the microenvironment by stromal caveolin-1 favors tumor invasion and metastasis publication-title: Cell – volume: 9 start-page: 4297 year: 2010 end-page: 4306 ident: bib0285 article-title: The autophagic tumor stroma model of cancer or “battery-operated tumor growth”: a simple solution to the autophagy paradox publication-title: Cell Cycle – volume: 42 start-page: 438 year: 2010 end-page: 445 ident: bib0215 article-title: Increased caveolin-1 expression associated with prolonged overall survival rate in hepatocellular carcinoma publication-title: Pathology – volume: 72 start-page: 4405 year: 2012 end-page: 4416 ident: bib0205 article-title: Functional interaction of tumor suppressor DLC1 and caveolin-1 in cancer cells publication-title: Cancer Res – volume: 25 start-page: 2586 year: 2007 end-page: 2593 ident: bib0240 article-title: Intratumoral balance of regulatory and cytotoxic T cells is associated with prognosis of hepatocellular carcinoma after resection publication-title: J Clin Oncol – volume: 366 start-page: 1156 year: 2012 end-page: 1158 ident: bib0265 article-title: Tumor-cell death, autophagy, and immunity publication-title: N Engl J Med – volume: 72 start-page: 4097 year: 2012 end-page: 4109 ident: bib0270 article-title: Caveolin-1 increases aerobic glycolysis in colorectal cancers by stimulating HMGA1-mediated GLUT3 transcription publication-title: Cancer Res – volume: 72 start-page: 655 year: 2012 end-page: 665 ident: bib0180 article-title: A novel FoxM1-caveolin signaling pathway promotes pancreatic cancer invasion and metastasis publication-title: Cancer Res – volume: 10 start-page: 4250 year: 2011 end-page: 4255 ident: bib0185 article-title: Loss of stromal caveolin-1 expression in malignant melanoma metastases predicts poor survival publication-title: Cell Cycle – volume: 345 start-page: 486 year: 2006 end-page: 494 ident: bib0255 article-title: Divergent expression and roles for caveolin-1 in mouse hepatocarcinoma cell lines with varying invasive ability publication-title: Biochem Biophys Res Commun – volume: 71 start-page: 4932 year: 2011 end-page: 4943 ident: bib0190 article-title: Caveolin-1 upregulation mediates suppression of primary breast tumor growth and brain metastases by stat3 inhibition publication-title: Cancer Res – volume: 130 start-page: 460 year: 2004 end-page: 468 ident: bib0220 article-title: Stepwise metastatic human hepatocellular carcinoma cell model system with multiple metastatic potentials established through consecutive in vivo selection and studies on metastatic characteristics publication-title: J Cancer Res Clin Oncol – volume: 379 start-page: 1245 year: 2012 end-page: 1255 ident: bib0155 article-title: Hepatocellular carcinoma publication-title: Lancet – volume: 226 start-page: 645 year: 2012 end-page: 653 ident: bib0200 article-title: Caveolin-1 overexpression is associated with hepatocellular carcinoma tumourigenesis and metastasis publication-title: J Pathol – volume: 7 start-page: 1159 year: 2011 end-page: 1172 ident: bib0230 article-title: Targeting autophagy enhances sorafenib lethality for hepatocellular carcinoma via ER stress-related apoptosis publication-title: Autophagy – volume: 9 start-page: 416 year: 2003 end-page: 423 ident: bib0225 article-title: Predicting hepatitis B virus-positive metastatic hepatocellular carcinomas using gene expression profiling and supervised machine learning publication-title: Nat Med – volume: 2 start-page: 120 year: 2012 ident: bib0160 article-title: Caveolae, caveolins, cavins, and endothelial cell function: new insights publication-title: Front Physiol – volume: 273 start-page: 117 year: 2009 end-page: 162 ident: bib0165 article-title: The biology of caveolae: achievements and perspectives publication-title: Int Rev Cell Mol Biol – volume: 30 start-page: 4498 year: 2011 end-page: 4508 ident: bib0235 article-title: IRX1 influences peritoneal spreading and metastasis via inhibiting BDKRB2-dependent neovascularization on gastric cancer publication-title: Oncogene – volume: 29 start-page: 977 year: 2012 end-page: 984 ident: bib0210 article-title: Caveolin-1 is related to invasion, survival, and poor prognosis in hepatocellular cancer publication-title: Med Oncol – volume: 61 start-page: 69 year: 2011 ident: 10.1016/j.clinre.2015.06.017_bib0150 article-title: Global cancer statistics publication-title: CA Cancer J Clin doi: 10.3322/caac.20107 – volume: 72 start-page: 655 year: 2012 ident: 10.1016/j.clinre.2015.06.017_bib0180 article-title: A novel FoxM1-caveolin signaling pathway promotes pancreatic cancer invasion and metastasis publication-title: Cancer Res doi: 10.1158/0008-5472.CAN-11-3102 – volume: 9 start-page: 416 year: 2003 ident: 10.1016/j.clinre.2015.06.017_bib0225 article-title: Predicting hepatitis B virus-positive metastatic hepatocellular carcinomas using gene expression profiling and supervised machine learning publication-title: Nat Med doi: 10.1038/nm843 – volume: 10 start-page: 4250 year: 2011 ident: 10.1016/j.clinre.2015.06.017_bib0185 article-title: Loss of stromal caveolin-1 expression in malignant melanoma metastases predicts poor survival publication-title: Cell Cycle doi: 10.4161/cc.10.24.18551 – volume: 48 start-page: 497 year: 2008 ident: 10.1016/j.clinre.2015.06.017_bib0245 article-title: Expression of X-linked inhibitor-of-apoptosis protein in hepatocellular carcinoma promotes metastasis and tumor recurrence publication-title: Hepatology doi: 10.1002/hep.22393 – volume: 9 start-page: 4297 year: 2010 ident: 10.1016/j.clinre.2015.06.017_bib0285 article-title: The autophagic tumor stroma model of cancer or “battery-operated tumor growth”: a simple solution to the autophagy paradox publication-title: Cell Cycle doi: 10.4161/cc.9.21.13817 – volume: 43 start-page: 1045 year: 2011 ident: 10.1016/j.clinre.2015.06.017_bib0280 article-title: Stromal-epithelial metabolic coupling in cancer: integrating autophagy and metabolism in the tumor microenvironment publication-title: Int J Biochem Cell Biol doi: 10.1016/j.biocel.2011.01.023 – volume: 130 start-page: 460 year: 2004 ident: 10.1016/j.clinre.2015.06.017_bib0220 article-title: Stepwise metastatic human hepatocellular carcinoma cell model system with multiple metastatic potentials established through consecutive in vivo selection and studies on metastatic characteristics publication-title: J Cancer Res Clin Oncol doi: 10.1007/s00432-004-0564-9 – volume: 72 start-page: 4405 year: 2012 ident: 10.1016/j.clinre.2015.06.017_bib0205 article-title: Functional interaction of tumor suppressor DLC1 and caveolin-1 in cancer cells publication-title: Cancer Res doi: 10.1158/0008-5472.CAN-12-0777 – volume: 71 start-page: 4932 year: 2011 ident: 10.1016/j.clinre.2015.06.017_bib0190 article-title: Caveolin-1 upregulation mediates suppression of primary breast tumor growth and brain metastases by stat3 inhibition publication-title: Cancer Res doi: 10.1158/0008-5472.CAN-10-4249 – volume: 7 start-page: 1159 year: 2011 ident: 10.1016/j.clinre.2015.06.017_bib0230 article-title: Targeting autophagy enhances sorafenib lethality for hepatocellular carcinoma via ER stress-related apoptosis publication-title: Autophagy doi: 10.4161/auto.7.10.16818 – volume: 345 start-page: 486 year: 2006 ident: 10.1016/j.clinre.2015.06.017_bib0255 article-title: Divergent expression and roles for caveolin-1 in mouse hepatocarcinoma cell lines with varying invasive ability publication-title: Biochem Biophys Res Commun doi: 10.1016/j.bbrc.2006.03.246 – volume: 18 start-page: 3042 year: 2012 ident: 10.1016/j.clinre.2015.06.017_bib0250 article-title: Decreased selenium-binding protein 1 enhances glutathione peroxidase 1 activity and downregulates HIF-1alpha to promote hepatocellular carcinoma invasiveness publication-title: Clin Cancer Res doi: 10.1158/1078-0432.CCR-12-0183 – volume: 7 start-page: 423 year: 2012 ident: 10.1016/j.clinre.2015.06.017_bib0275 article-title: Caveolin-1 and cancer metabolism in the tumor microenvironment: markers, models, and mechanisms publication-title: Annu Rev Pathol doi: 10.1146/annurev-pathol-011811-120856 – volume: 2 start-page: 120 year: 2012 ident: 10.1016/j.clinre.2015.06.017_bib0160 article-title: Caveolae, caveolins, cavins, and endothelial cell function: new insights publication-title: Front Physiol doi: 10.3389/fphys.2011.00120 – volume: 146 start-page: 148 year: 2011 ident: 10.1016/j.clinre.2015.06.017_bib0290 article-title: Biomechanical remodeling of the microenvironment by stromal caveolin-1 favors tumor invasion and metastasis publication-title: Cell doi: 10.1016/j.cell.2011.05.040 – volume: 30 start-page: 4498 year: 2011 ident: 10.1016/j.clinre.2015.06.017_bib0235 article-title: IRX1 influences peritoneal spreading and metastasis via inhibiting BDKRB2-dependent neovascularization on gastric cancer publication-title: Oncogene doi: 10.1038/onc.2011.154 – volume: 72 start-page: 4097 year: 2012 ident: 10.1016/j.clinre.2015.06.017_bib0270 article-title: Caveolin-1 increases aerobic glycolysis in colorectal cancers by stimulating HMGA1-mediated GLUT3 transcription publication-title: Cancer Res doi: 10.1158/0008-5472.CAN-12-0448 – volume: 379 start-page: 1245 year: 2012 ident: 10.1016/j.clinre.2015.06.017_bib0155 article-title: Hepatocellular carcinoma publication-title: Lancet doi: 10.1016/S0140-6736(11)61347-0 – volume: 587 start-page: 782 year: 2013 ident: 10.1016/j.clinre.2015.06.017_bib0195 article-title: Caveolin-1 up-regulates integrin alpha2,6-sialylation to promote integrin alpha5beta1-dependent hepatocarcinoma cell adhesion publication-title: FEBS Lett doi: 10.1016/j.febslet.2013.02.002 – volume: 29 start-page: 977 year: 2012 ident: 10.1016/j.clinre.2015.06.017_bib0210 article-title: Caveolin-1 is related to invasion, survival, and poor prognosis in hepatocellular cancer publication-title: Med Oncol doi: 10.1007/s12032-011-9900-5 – volume: 50 start-page: 204 year: 2014 ident: 10.1016/j.clinre.2015.06.017_bib0170 article-title: Caveolin-1 promotes gastric cancer progression by up-regulating epithelial to mesenchymal transition by crosstalk of signalling mechanisms under hypoxic condition publication-title: Eur J Cancer doi: 10.1016/j.ejca.2013.08.016 – volume: 73 start-page: 1900 year: 2013 ident: 10.1016/j.clinre.2015.06.017_bib0175 article-title: Caveolin-1-LRP6 signaling module stimulates aerobic glycolysis in prostate cancer publication-title: Cancer Res doi: 10.1158/0008-5472.CAN-12-3040 – volume: 273 start-page: 117 year: 2009 ident: 10.1016/j.clinre.2015.06.017_bib0165 article-title: The biology of caveolae: achievements and perspectives publication-title: Int Rev Cell Mol Biol doi: 10.1016/S1937-6448(08)01804-2 – volume: 42 start-page: 438 year: 2010 ident: 10.1016/j.clinre.2015.06.017_bib0215 article-title: Increased caveolin-1 expression associated with prolonged overall survival rate in hepatocellular carcinoma publication-title: Pathology doi: 10.3109/00313025.2010.494293 – volume: 226 start-page: 645 year: 2012 ident: 10.1016/j.clinre.2015.06.017_bib0200 article-title: Caveolin-1 overexpression is associated with hepatocellular carcinoma tumourigenesis and metastasis publication-title: J Pathol doi: 10.1002/path.3957 – volume: 25 start-page: 2586 year: 2007 ident: 10.1016/j.clinre.2015.06.017_bib0240 article-title: Intratumoral balance of regulatory and cytotoxic T cells is associated with prognosis of hepatocellular carcinoma after resection publication-title: J Clin Oncol doi: 10.1200/JCO.2006.09.4565 – volume: 9 start-page: 65 year: 2009 ident: 10.1016/j.clinre.2015.06.017_bib0260 article-title: Differential expression of Caveolin-1 in hepatocellular carcinoma: correlation with differentiation state, motility and invasion publication-title: BMC Cancer doi: 10.1186/1471-2407-9-65 – volume: 366 start-page: 1156 year: 2012 ident: 10.1016/j.clinre.2015.06.017_bib0265 article-title: Tumor-cell death, autophagy, and immunity publication-title: N Engl J Med doi: 10.1056/NEJMcibr1114526 |
SSID | ssj0000450871 |
Score | 2.248162 |
Snippet | Caveolin-1 is a member of the caveolae family of membrane proteins. Although some researchers have investigated the function of Caveolin-1 in hepatocellular... Summary Background Caveolin-1 is a member of the caveolae family of membrane proteins. Although some researchers have investigated the function of Caveolin-1... |
SourceID | proquest pubmed crossref elsevier |
SourceType | Aggregation Database Index Database Enrichment Source Publisher |
StartPage | 169 |
SubjectTerms | Autophagy - physiology Carcinoma, Hepatocellular - metabolism Carcinoma, Hepatocellular - pathology Carcinoma, Hepatocellular - secondary Caveolin 1 - biosynthesis Caveolin 1 - physiology Cell Proliferation Female Gastroenterology and Hepatology Humans Internal Medicine Liver Neoplasms - metabolism Liver Neoplasms - pathology Male Middle Aged Prognosis Tumor Cells, Cultured |
Title | Caveolin-1 promotes tumor growth and metastasis via autophagy inhibition in hepatocellular carcinoma |
URI | https://www.clinicalkey.com/#!/content/1-s2.0-S2210740115001539 https://www.clinicalkey.es/playcontent/1-s2.0-S2210740115001539 https://www.ncbi.nlm.nih.gov/pubmed/26206578 https://www.proquest.com/docview/1778707217 |
Volume | 40 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb9QwELaWIiEuiDfLS0bihrzKO9kjqqiqqnCAVtqbFTuTbip2U-0mPXDgd_BzmbGdR2lXBS5RlNjZjefLjGc08w1j7_0kDotU44cEWSKiaF4KNHpK5JCjhVC-B2CyLb4kh6fR0SJeTCa_RllLbaNm-seNdSX_I1W8hnKlKtl_kGz_ULyA5yhfPKKE8fhXMt7PL4Ga7gif8qxw0YmvoV3Vmw9n6F27orUVNDluAYl45JIqsFqiEshNvd-yUlWX7LhEu9TUFMc3iamaegyta6e1OyoDU0ZpWZ0dS9BymNuTOZ3h721qIvvcXAnaH1etSemDSnwdKtCOLIvBMVR9FKGyUVnKuBWLajTSBbcXlThww13Awk9GeS5GrwXoZQpqBGhN0Pia6Z7TK2bL4-QAGIy0rG-7u1zT_jYQcT6jotINcaD6sSFntdWhI0BcrAwiiIw_iW0LoT9Yt7tbd9jdAB0Q6o0x--n30TvcCHuZ8eb7t-nqMk3y4PV_QKzT7pm7tkC7XByz1Tl5yB44H4V_tIB7xCawfszufXZZGE9YMeCOd7jjBnfc4o4jCviAO4644z3u-IA7POVXccd73D1lpwefTvYPhevWIXSU-Y1QaBkSDVlRxvPMg0irMtJF4kGgUojLEopwnkFcaOWrwAMdopJAbyLKgmJe5KDCZ2xvXa_hBeNKl7lXxlAWqogA4hzdQJ3F4JWRl-ssmbKwW0CpHZU9dVT5LrucxXNpJSBJApJSN_10ykQ_68JSudwyPu5kI7syZTSsEtF2y7z0pnmwdZpjK325DaQnvxF2CDrolOH0cD5l7zoISNTytPT5GuoWZ6RkWNOAnv7cYqN_hw5WL3feecXuDx_ia7bXbFp4g3vpRr01sP4NFXvMIQ |
linkProvider | Elsevier |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Caveolin-1+promotes+tumor+growth+and+metastasis+via+autophagy+inhibition+in+hepatocellular+carcinoma&rft.jtitle=Clinics+and+research+in+hepatology+and+gastroenterology&rft.au=Liu%2C+Wei-Ren&rft.au=Jin%2C+Lei&rft.au=Tian%2C+Meng-Xin&rft.au=Jiang%2C+Xi-Fei&rft.date=2016-04-01&rft.issn=2210-7401&rft.eissn=2210-741X&rft.volume=40&rft.issue=2&rft.spage=169&rft_id=info:doi/10.1016%2Fj.clinre.2015.06.017&rft_id=info%3Apmid%2F26206578&rft.externalDocID=26206578 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=2210-7401&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=2210-7401&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=2210-7401&client=summon |